Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines focusing on central nervous system disorders. The company has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors.

AgroFresh Solutions delivers food preservation and waste reduction solutions for fresh produce. The company's products are: SmartFresh, which regulates the post-harvest ripening effects of ethylene; Harvista, which provides treatment of cherries and blueberries early in the growing season, and near-harvest management of apples and pears; FreshCloud Storage Insights?, which is an atmospheric monitoring system that provides guidance to producers and packers of fresh produce regarding storage conditions; LandSpring?, which is 1-Methylcyclopropene technology targeted to transplanted vegetable seedlings; and RipeLock, which is a packaging-based freshness technology solutions for fruits and vegetables.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Axogen provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include: Avance Nerve Graft, which is an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector, which is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector, which is a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

Ladenburg Thalmann Financial Services is a financial services company. The company has three operating segments: the independent advisory and brokerage services, which includes the investment advisory and brokerage services provided by the company's independent advisory and brokerage subsidiaries to their independent contractor financial advisors and the wealth management services; the Ladenburg, which includes the investment banking, sales and trading and asset management services and investment activities; and the insurance brokerage, which includes the wholesale insurance brokerage activities provided by the company's subsidiaries, Highland Capital Brokerage, which delivers fixed and equity indexed annuities.

Macquarie Infrastructure is a holding company. The company owns and operates a portfolio of businesses that provide services to other businesses, government agencies and individuals primarily in the U.S. The businesses the company owns and operate are: International-Matex Tank Terminals, which provides bulk liquid terminalling services to third parties in the U.S. and in Canada; Atlantic Aviation, which provides fuel, terminal, aircraft hangaring and other services primarily to owners and operators of general aviation jet aircraft at airports throughout the U.S.; and MIC Hawaii, which consist of energy company that processes and distributes gas and provides related services.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

Univar Solutions is a chemical and ingredient distributor and provider of services. The company purchases chemicals and ingredients from chemical producers worldwide to warehouse, repackage, blend, dilute, transport and sell those chemicals to various customer locations across various countries. The company's business is organized and managed in four geographical segments: Univar Solutions USA, Univar Solutions Canada, Univar Solutions Europe and the Middle East and Africa, and Univar Solutions Latin America, which includes developing businesses in Latin America (including Brazil and Mexico) and the Asia-Pacific region.